Peripheral Blood Stem Cell Mobilization by Chemotherapy with and without Recombinant Human Granulocyte Colony-Stimulating Factor

Journal of Hematotherapy and Stem Cell Research

Volumn 1, Issue 4, 1992, Pages 317-327

  Schwartzberg, Lee S ^a   Birch, Robert ^a   Hazelton, Bonni ^a   Tauer, Kurt W ^a   Lee, Paul ^a   Altemose, Rand ^a   George, Christopher ^a   Blanco, Ralph ^a   Wittlin, Fred ^a   Cohen, James ^a   Muscato, Joseph ^a   West, William H ^a  

^a Response Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; LEUKOCYTE ANTIGEN; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CELL COUNT; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; MALE;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL COUNT; COMPARATIVE STUDY; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMAN; MALE; MIDDLE AGE; RECOMBINANT PROTEINS;

EID: 0027019408     PISSN: 15258165     EISSN: none     Source Type: Journal    
DOI: 10.1089/scd.1.1992.1.317     Document Type: Article

References (35)

1. Andrews, R.G., Singer, J.W. & Bernstein, I.D. (1989): Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD-33 and CD-34 antigens and light scatter properties. J. Exp. Med. 169: 1721.
2. Camtin, G., Marchand-Laroche, D., Bouchard, M.-M. et al. (1989): Blood-derived stem cell collection in acute non-lymphoblastic leukemia: Predictive values fora good yield. Exp. Hematol. 17: 991.
3. Damon, L.E. & Cadman, E.C. (1988): The metabolic basis for combination chemotherapy. Pharmacol. Ther. 38: 73.
4. DeVita, V.T., Jr., Young, R.C. & Canellos, G.P. (1975): Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer. Cancer 35: 98.
5. Duhrsen, U., Villeval, J., Boyd, J. et al. (1988): Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 72: 2074.
6. Fermand, J.P., Levy, Y., Gerota, J. etal. (1989): Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graft. Blood 73: 20.
7. Gianni, A.M., Bregni. M., Stern, A.C. et al. (1989): Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 2: 580.
8. Gianni. A.M., Bregni, M., Siena, S. et al. (1990): Recombinant human granulocyte-macrophage colony stimulator factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J. Clin. Oncol. 8: 768.
9. Haas, R., Ho, A.D., Bredthauer, V. et al. (1990): Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. Exp. Hematol. 18: 94.
10. Haas, R., Hohaus, S., Ogniben, E. et al. (1991): Autologous transplantation of blood stem cells mobilized with rhGM-CSF subsequent to chemotherapy. Exp. Hematol. 19: 513A.
11. Henon, P.R., Butturini, A. & Gale, R.P. (1991): Blood-derived haematopoietic cell transplants: Blood to Blood? Lancet 337:961.
12. Ho, A.D., Rainer, H., Korbling, M. et al. (1991): Utilization of recombinant human GM-CSF to enhance peripheral progenitor cell yield for autologous transplantation. Bone Marrow Transplant. (Suppl. 2): 13.
13. Juttner, C.A. & To, L.B.: Peripheral stem cells: Mobilization by myelosuppressive chemotherapy. In Autologous Bone Marrow Transplantation Proc Fifth International Symposium, eds. Dicke, K.A., Armitage. J.Q., Dicke-Enger. M.J.: Omaha, 1991, pp 9783–9790.
14. Juttner, C.A., To, L.B., Ho, J.Q. et al. (1988): Early lympho-hemopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia. Transplant Proc. 20: 40.
15. Juttner, C.A., To, L.B., Haylock, D.N. etal. (1989): Autologous blood stem cell transplantation. Transplant Proc. 21: 2929.
16. Kessinger. A. & Armitage, J.O. (1991): The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 77: 211.
17. Kessinger, A., Armitage, J.O., Smith, D.M., etal. (1989): High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 74: 1260.
18. Korbling, M., Holle, R., Haas, R. et al. (1990): Autologous blood stem-cell transplantation in patients with advanced hodgkin's disease and prior radiation to the pelvic site. J. Clin. Oncol. 8: 978.
19. Lasky, L.C. (1989): Hematopoietic reconstitution using progenitors recovered from blood. Transfusion 29: 552.
20. Leary, A.G., Ogawa, M., Strauss, L.C. et al. (1984): Single cell origin of multi-lineage colonies in culture. J. Clin. Invest. 84:2193.
21. Lopez, M., Mortel, O., Pouillart, P. et al. (1991): Acceleration of hemopoietic recovery after autologous bone marrow transplantation by low doses of peripheral blood stem cells. Bone Marrow Transplant. 7: 173.
22. Mauch, P., Ferrara, J. & Hellman, S. (1989): Stem cell self-renewal considerations in bone marrow transplantation. Bone Marrow Transplant. 4: 601.
23. Rabinowitz, A., Watkins. K., Rosen, P. et al. (1991): Autologous peripheral stem cells (PBC) during marrow recovery shorten duration of neutropenia in transplant patients. Proc. Am. Soc. Clin. Oncol. 10: 333A.
24. Ravagnani, F., Siena, S., Bregni, M. et al. (1990): Large-scale collection of circulating haematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF. Eur. J. Cancer 26: 562.
25. Reiffers, J., Bernard, P., David, B., et al. (1986 a): Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia. Exp. Hematol. 14: 312.
26. Reiffers, J., Bernard, D.H., Marit, G. et al. (1986 b): Collection of blood-derived hematopoietic stem cells and application for autologous transplantation. Bone Marrow Transplant. (Suppl. 1) 1:371.
27. Schwartzberg, L., West, W., Birch, R. etal. (1991): Mobilized peripheral blood stem cells (PBSC) alone for hematologic reconstitution after high-dose chemotherapy for advanced malignancy. Proc. Am. Soc. Clin. Oncol. 10: 332A.
28. Sheridan, W.P., Morstyn, G., Wolf, M. et al. (1989): Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 2: 891.
29. Siena, S., Bregni, M., Brando, B. etal. (1989): Circulating of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhanced by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 74: 1904.
30. Siena, S., Bregni, M., Brando, B. et al. (1991): Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77: 400.
31. Socinski, M.A., Elias, A., Schnipper, L. et al. (1988): Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1: 1194.
32. Tarella, C, Ferrero, D., Bregni, M. et al. (1991): Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF. Eur. J. Cancer 27: 22.
33. To, L.B., Haylock, D.N., Kimber, R.J. et al. (1984): High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukemia and their collection and cryopreservation. Br. J. Haematol. 58: 399.
34. To, L.B., Dyson, P.G. & Juttner, C.A. (1986): Cell-dose effect in circulating stem-cell autografting. Lancet 2: 404.
35. To, L.B., Shepperd, K.M., Haylock, D.N. etal. (1990): Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp. Hematol. 18: 442.